Volume control in peritoneal dialysis patients: Role of new dialysis solutions

被引:10
|
作者
Lameire, N [1 ]
机构
[1] Univ Hosp, Div Renal, BE-9000 Ghent, Belgium
关键词
biocompatibility; glucose degradation products; left ventricular hypertrophy; peritoneal dialysis; ultrafiltration failure; volume control;
D O I
10.1159/000074923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper reviews the most recent clinical data on the volume status of long-term peritoneal dialysis (PD) patients. It appears that many PD patients are volume overloaded, associated with a high prevalence of hypertension and left ventricular hypertrophy. In the presence of the poor results in patients with peritoneal ultrafiltration, the introduction of the polyglucose solution, icodextrin, has ameliorated volume control in some of these patients. In a second part of the review, some of the structural and functional alterations in the peritoneal membrane and the role of glucose degradation products (GDP) in the commonly used dialysates as well as the resulting formation of advanced glycation end products are described. The introduction of low GDP-containing solutions at normal pH has at least in experimental models of PD attenuated the hemodynamic changes observed with the classical solutions. The solutions at normal pH containing either bicarbonate or a mixture of bicarbonate/lactate were clinically associated with less inflow pain. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:44 / 54
页数:11
相关论文
共 50 条
  • [31] THE ROLE OF NGAL IN PERITONEAL DIALYSIS EFFLUENT IN EARLY DIAGNOSIS OF PERITONITIS: CASE-CONTROL STUDY IN PERITONEAL DIALYSIS PATIENTS
    Martino, Francesca
    Scalzotto, Elisa
    Giavarina, Davide
    Rodighiero, Maria Pia
    Crepaldi, Carlo
    Day, Sonya
    Ronco, Claudio
    PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (05): : 559 - 565
  • [32] Volume management in peritoneal dialysis
    Hafer C.
    Der Nephrologe, 2017, 12 (1): : 14 - 19
  • [33] Volume management in peritoneal dialysis
    Potthoff, Sebastian Alexander
    NEPHROLOGE, 2022, 17 (02): : 74 - 84
  • [34] Peritoneal damage by peritoneal dialysis solutions
    Ito, Takafumi
    Yorioka, Noriaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2008, 12 (04) : 243 - 249
  • [35] Volume management in peritoneal dialysis
    Potthoff, Sebastian Alexander
    NEPHROLOGIE, 2022, 17 (02): : 74 - 84
  • [36] Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: Will new dialysis solutions prevent these changes?
    Krishnan M.
    Tam P.
    Wu G.
    Breborowicz A.
    Oreopoulos D.G.
    International Urology and Nephrology, 2005, 37 (2) : 409 - 418
  • [37] VOLUME STATUS IN PERITONEAL DIALYSIS
    Woodrow, Graham
    PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 : S77 - S82
  • [38] Peritoneal damage by peritoneal dialysis solutions
    Takafumi Ito
    Noriaki Yorioka
    Clinical and Experimental Nephrology, 2008, 12 : 243 - 249
  • [39] Evidence-based medicine in peritoneal dialysis: Peritoneal dialysis solutions
    Feriani, M
    PERITONEAL DIALYSIS TODAY, 2003, 140 : 202 - 208
  • [40] Real body fluid volume in peritoneal dialysis patients
    Jakic, M
    Mihaljevic, D
    Zibar, L
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V348 - V349